ReviewExpert opinion on pharmacotherapy2009
Pharmacotherapy of postpartum depression.
Review in Expert opinion on pharmacotherapy, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01796132 (Antidepressant Treatments During Pregnancy and Lactation), which is not on this map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Antidepressant Treatments During Pregnancy and Lactation: Prediction of Drug Exposure Through Breastfeeding and Evaluation of Drug Effect on the Neonatal Adaptation and the Development of the Young Child
Who cites it
14 citing papers in PubMed, 42 citations in OpenAlex.
- Perinatal Anxiety and Depression During COVID-19.The journal for nurse practitioners : JNP · 2021Article
- Pharmacological sex hormone manipulation as a risk model for depression.Journal of neuroscience research · 2020Review
- Cost-Effectiveness of Brexanolone Versus Selective Serotonin Reuptake Inhibitors for the Treatment of Postpartum Depression in the United States.Journal of managed care & specialty pharmacy · 2020Article
- Pathophysiological mechanisms implicated in postpartum depression.Frontiers in neuroendocrinology · 2019Review
- Psychoactive drug exposure during breastfeeding: a critical need for preclinical behavioral testing.Psychopharmacology · 2018Review
- Risk, treatment duration, and recurrence risk of postpartum affective disorder in women with no prior psychiatric history: A population-based cohort study.PLoS medicine · 2017Article
- Overcoming functional impairment in postpartum depressed or anxious women: a pilot trial of desvenlafaxine with flexible dosing.Therapeutic advances in psychopharmacology · 2016Article
- Can Postpartum Depression Be Managed in Pediatric Primary Care?Journal of women's health (2002) · 2016Review
- Relationship of monoamine oxidase-A distribution volume to postpartum depression and postpartum crying.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2015Article
- Perinatal depression: an update and overview.Current psychiatry reports · 2014Review
- Pharmacotherapy of postpartum depression: an update.Expert opinion on pharmacotherapy · 2014Review
- Are antidepressants effective in the treatment of postpartum depression? A systematic review.The primary care companion for CNS disorders · 2013Review
- Emerging risk factors for postpartum depression: serotonin transporter genotype and omega-3 fatty acid status.Canadian journal of psychiatry. Revue canadienne de psychiatrie · 2012Review
- Avoiding risk at what cost? Putting use of medicines for breastfeeding women into perspective.International breastfeeding journal · 2012Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
Abstract
backgroundThe prevalence and recurrence rates of postpartum depression (PPD) are 13 and 25%, respectively. Despite its detrimental impact on the health of the mother-infant dyad, there is a paucity of data in the literature regarding the efficacy of pharmacological treatment of PPD.
objectivesi) To review the literature on the use of antidepressants and hormonal supplements for the prevention and the treatment of PPD; ii) to give the authors' opinion on the current status of the pharmacological treatment of PPD; and iii) to discuss developments that are likely to be important in the future.
methodsAn electronic search was performed by using PubMed, Medline, and PsychINFO. Inclusion criteria were: i) empirical articles in peer-reviewed English-language journals; ii) well-validated measures of depression; and iii) a uniform scoring system for depression among the sample. RESULTS/
conclusionThe electronic search yielded a total of 19 articles (12 on treatment and 7 on prevention of PPD) with the following study designs: eight randomized clinical trials (six using placebo control and two using active control groups), and 11 open-label studies. The selection of the specific antidepressant for a woman with PPD should derive from a personalized risk-benefit analysis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.